EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery

Yue Yang, Hao Cheng iD

Biomolecules · 2024

DOI: 10.3390/biom14111364 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Yue Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Drug Discovery, RNA, Untranslated. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM), a high-incidence chronic metabolic disorder, has emerged as a global health issue, where most patients need lifelong medication. Gaining insights into molecular mechanisms involved in T2DM development is expected to provide novel strategies for clinical prevention and treatment. Growing evidence validates that non-coding RNAs (ncRNAs) including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) function as crucial regulators in multiple biological processes of T2DM, inspiring various potential targets and drug candidates. In this review, we summarize the current understanding of ncRNA roles in T2DM and discuss the potential use of ncRNAs as targets and active molecules for drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Drug DiscoveryRNA, UntranslatedHumansRNA, CircularMicroRNAsAnimalsRNA, Long Noncoding

Stichwörter der Autor:innen

T2DMdrug discoveryncRNA drug deliveryncRNAsregulatory mechanism

Substanzen

RNA, UntranslatedRNA, CircularMicroRNAsRNA, Long Noncoding

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
  • State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Hao Cheng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Fundamental Research Funds for the Central Universities
  • China Postdoctoral Science Foundation
  • Jiangsu Province Outstanding Postdoctoral Program

Zitieren

APA

Yang, Y., & Cheng, H. (2024). Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery. Biomolecules. https://doi.org/10.3390/biom14111364

Vancouver

Yang Y, Cheng H. Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery. Biomolecules. 2024. doi:10.3390/biom14111364

BibTeX
@article{Yang2024,
  author = {Yang, Yue and Cheng, Hao},
  title = {Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14111364}
}
Kostenlos starten →